Public-registry trials using Bimatoprost (SR) that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension | AbbVie | Open-Angle Glaucoma | PHASE3 | 108 |
| First registered study | September 2014 — NCT02247804 (Allergan) |
| Registered studies matching this name | 8 all-time · 0 currently recruiting |
Source: ClinicalTrials.gov, the public trial registry.
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
← Eichor home · All tracked trials · Open-Angle Glaucoma studies · Weekly briefs